Intégrité scientifique

Scientific Integrity

Scientific integrity is a fundamental value whose defense requires vigilance and requirement from all the actors in research.

The stakes are high:

  • contributing to knowledge
  • providing public confidence in science

Integrity and honesty are requirements applicable to all scientific research.

Gustave Roussy has thus subscribed to the national charter of scientific integrity proposed on June 29, 2016 by Professor Pierre Corvol to Mr. Thierry Mandon, Secretary of State for Higher Education and Research.

CD8 T-cell immunity and immunotherapy in lung cancer

CD8 T-cell immunity and immunotherapy in lung cancer

This group belongs to the UMR 1186 - Integrative tumor immunology and immunotherapy

Despite advances in immunotherapy, a large fraction of cancer patients fails to respond. Immune mechanisms behind this resistance are poorly elucidated. The objective of our research program is to comprehensively characterize and study the role of a new class of white blood cells, called resident memory T cells (TRM), in antitumor immunity and response to cancer immunotherapy.

La réparation de l'ADN

La réparation de l'ADN

L'ADN code notre information génétique. Très souvent, le cancer part d'une erreur dans le code génétique d'une cellule que les systèmes de réparation de l'ADN n'ont pas pu détecter ou réparer.

C'est pourquoi l'étude de l'ADN et des mécanismes de réparation responsables de son intégrité est un axe stratégique fort de la recherche à Gustave Roussy.

REISAMIC register

Registry of Severe Adverse Reactions to Immunomodulatory Antibodies used in Oncology (REISAMIC)

Unité Fonctionnelle de PharmacoVigilance - Equipe

Membres de l'Unité Fonctionnelle de PharmacoVigilance

 

  • Responsable 
    Dr Salim Laghouati
  • Chargées de Pharmacovigilance
    Dr Audrey Lallart
    Dr Anne-Laure Voisin
  • Assistant de Pharmacovigilance 
    Geoffray Cengizalp
  • Responsable Assurance Qualité 
    Dr Sylvie Demirdjian

EN - Espèces Réactives de l'Oxygène et Radiocarcinogenèse - Membres

  • Corinne DUPUY, CNRS Research Director, Group leader
  • Martin SCHLUMBERGER, PU-PH GR,  Chief of the Nuclear Medicine department, Director of l’école des Sciences du Cancer et Director of l’école Doctorale de Cancérologie (ED418)
  • Abir Al Ghuzlan, PH Gustave Roussy, Anatomopathologist
  • Rabii Ameziane El Hassani, CNRS Post-doc
  • Ruy Andrade Louzada Neto, Gustave Roussy Post-doct
  • Raphaël Corre, Assistant Ingénieur, Gustave Roussy CDD
  • Naïma Azouzi, Doctorante, thesis defense in may 2016

Pages